Association with Genetic Variants in the IL-23 and NF-κB Pathways Discriminates between Mild and Severe Psoriasis Skin Disease

Journal of Investigative Dermatology

Volumn 135, Issue 8, 2015, Pages 1969-1976

  Nikamo, Pernilla ^a   Lysell, Josefin ^a   Ståhle, Mona ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HLA C ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 21; INTERLEUKIN 23; INTERLEUKIN 23 RECEPTOR; DNA BINDING PROTEIN; HLA-C*06 ANTIGEN; IL23R PROTEIN, HUMAN; INTERLEUKIN 12; INTERLEUKIN DERIVATIVE; INTERLEUKIN RECEPTOR; TNIP1 PROTEIN, HUMAN;

ADULT; ARTICLE; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPING TECHNIQUE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PSORIASIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMIC THERAPY; ADOLESCENT; AGED; CASE CONTROL STUDY; CHILD; COHORT ANALYSIS; DIFFERENTIAL DIAGNOSIS; GENETICS; GENOTYPE; INFANT; MIDDLE AGED; PHENOTYPE; PRESCHOOL CHILD; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; DIAGNOSIS, DIFFERENTIAL; DNA-BINDING PROTEINS; FEMALE; FOLLOW-UP STUDIES; GENE FREQUENCY; GENETIC VARIATION; GENOTYPE; HLA-C ANTIGENS; HUMANS; INFANT; INTERLEUKIN-12; INTERLEUKIN-23; INTERLEUKINS; MALE; MIDDLE AGED; NF-KAPPA B; PHENOTYPE; PSORIASIS; RECEPTORS, INTERLEUKIN; SEVERITY OF ILLNESS INDEX; SIGNAL TRANSDUCTION; YOUNG ADULT;

EID: 84937622566     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/jid.2015.103     Document Type: Article

References (58)

1. Aggarwal S, Ghilardi N, Xie MH et al. (2003) Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J Biol Chem 278:1910-4
2. Andres RM, Hald A, Johansen C et al. (2013) Studies of Jak/STAT3 expression and signalling in psoriasis identifies STAT3-Ser727 phosphorylation as a modulator of transcriptional activity. Exp Dermatol 22:323-8
3. Baeuerle PA, Baltimore D (1996) NF-kB: ten years after. Cell 87:13-20
4. Baldwin AS (1996) The NF-κB and IκB proteins: new discoveries and insights. Ann Rev Immunol 14:649-81
5. Barnes PJ, Karin M (1997) Nuclear factor-κB-a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-71
6. Bettelli E, Carrier Y, Gao W et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441:235-8
7. Bowes J, Orozco G, Flynn E et al. (2011) Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Ann Rheum Dis 70:1641-4
8. Capon F, Di Meglio P, Szaub J et al. (2007) Sequence variants in the genes for the interleukin-23 receptor (IL23R) and its ligand (IL12B) confer protection against psoriasis. Hum Genet 122:201-6
9. Cargill M, Schrodi SJ, Chang M et al. (2007) A large-scale genetic association study confirms IL12B and leads to the identification of IL23R as psoriasis-risk genes. Am J Hum Genet 80:273-90
10. Caruso R, Costanzo A, Monteleone G (2009b) Pathogenic role of interleukin-21 in psoriasis. Cell Cycle 8:3629-30
11. Cen H, Zhou M, Leng RX et al. (2013) Genetic interaction between genes involved in NF-kappaB signaling pathway in systemic lupus erythemato-sus. Mol Immunol 56:643-8
12. Chua KH, Hilmi I, Lian LH et al. (2012) Association between inflammatory bowel disease gene 5 (IBD5) and interleukin-23 receptor (IL23R) genetic polymorphisms in Malaysian patients with Crohn's disease. J Dig Dis 13: 459-65
13. de Cid R, Riveira-Munoz E, Zeeuwen PL et al. (2009) Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat Genet 41:211-5
14. De La Concha EG, Fernandez-Arquero M, Lopez-Nava G et al. (2000) Susceptibility to severe ulcerative colitis is associated with polymorphism in the central MHC gene IKBL. Gastroenterology 119:1491-5
15. Dempsey PW, Vaidya SA, Cheng G (2003) The Art of War: innate and adaptive immune responses. CMLS, Cell Mol Life Sci 60:2604-21
16. Di Cesare A, Di Meglio P, Nestle FO (2009) The IL-23/Th17 axis in the immunopathogenesis of psoriasis. J Invest Dermatol 129:1339-50
17. Di Meglio P, Villanova F, Napolitano L et al. (2013) The IL23R A/Gln381 allele promotes IL-23 unresponsiveness in human memory T-helper 17 cells and impairs Th17 responses in psoriasis patients. J Invest Dermatol 133:2381-9
18. Dinu I, Mahasirimongkol S, Liu Q et al. (2012) SNP-SNP interactions discovered by logic regression explain Crohn's disease genetics. PLoS ONE 7:e43035
19. Duerr RH, Taylor KD, Brant SR et al. (2006) A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314: 1461-3
20. Eder L, Chandran V, Pellett F et al. (2011) IL13 gene polymorphism is a marker for psoriatic arthritis among psoriasis patients. Ann Rheum Dis 70:1594-8
21. Eiris N, Gonzalez-Lara L, Santos-Juanes J et al. (2014) Genetic variation at IL12B, IL23R and IL23A is associated with psoriasis severity, psoriatic arthritis and type 2 diabetes mellitus. J Dermatol Sci 75:167-72
22. Ellinghaus D, Ellinghaus E, Nair Rajan P et al. (2012) Combined analysis of genome-wide association studies for Crohn disease and psoriasis identifies seven shared susceptibility loci. Am J Hum Genet 90:636-47
23. Ellinghaus E, Ellinghaus D, Stuart PE et al. (2010) Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2. Nat Genet 42: 991-5
24. Fan X, Yang S, Sun LD et al. (2007) Comparison of clinical features of HLA-Cw∗0602-positive and-negative psoriasis patients in a Han Chinese population. Acta Derm Venereol 87:335-40
25. Franke A, McGovern DP, Barrett JC et al. (2010) Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 42:1118-25
26. Fredriksson T, Pettersson U (1978) Severe psoriasis-oral therapy with a new retinoid. Dermatologica 157:238-44
27. Giardina E, Pietrangeli I, Martinez-Labarga C et al. (2008) Haplotypes in SLC24A5 gene as ancestry informative markers in different populations. Curr Genomics 9:110-4
28. Greetham D, Ellis CD, Mewar D et al. (2007) Functional characterization of NF-κB inhibitor-like protein 1 (NFκBIL1), a candidate susceptibility gene for rheumatoid arthritis. Hum Mol Genet 16:3027-36
29. Huffmeier U, Uebe S, Ekici AB et al. (2010) Common variants at TRAF3IP2 are associated with susceptibility to psoriatic arthritis and psoriasis. Nat Genet 42:996-9
30. Ishizaki M, Muromoto R, Akimoto T et al. (2014) Tyk2 is a therapeutic target for psoriasis-like skin inflammation. Int Immunol 26:257-67
31. Julià A, Tortosa R, Hernanz JM et al. (2012) Risk variants for psoriasis vulgaris in a large case-control collection and association with clinical subpheno-types. Hum Mol Genet 21:4549-57
32. Jung C, Colombel JF, Lemann M et al. (2012) Genotype/phenotype analyses for 53 Crohn's disease associated genetic polymorphisms. PLoS ONE 7: e52223
33. Kikly K, Liu L, Na S et al. (2006) The IL-23/Th17 axis: therapeutic targets for autoimmune inflammation. Curr Opin Immunol 18:670-5
34. Langowski JL, Zhang X, Wu L et al. (2006) IL-23 promotes tumour incidence and growth. Nature 442:461-5
35. Leonardi CL, Kimball AB, Papp KA et al. (2008) Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1). Lancet 371:1665-74
36. Li H, Gao L, Shen Z et al. (2008) Association study of NFKB1 and SUMO4 polymorphisms in Chinese patients with psoriasis vulgaris. Arch Dermatol Res 300:425-33
37. Liang J, Tsui V, Van Abbema A et al. (2013) Lead identification of novel and selective TYK2 inhibitors. Eur J Med Chem 67:175-87
38. Liu Y, Helms C, Liao W et al. (2008) A genome-wide association study of psoriasis and psoriatic arthritis identifies new disease loci. PLoS Genet 4: e1000041
39. Lysell J, Padyukov L, Kockum I et al. (2013) Genetic association with ERAP1 in psoriasis is confined to disease onset after puberty and not dependent on HLA-C∗06. J Invest Dermatol 133:411-7
40. Marrakchi S, Guigue P, Renshaw BR et al. (2011) Interleukin-36-receptor antagonist deficiency and generalized pustular psoriasis. N Engl J Med 365:620-8
41. Nair RP, Duffin KC, Helms C et al. (2009) Genome-wide scan reveals association of psoriasis with IL-23 and NF-κB pathways. Nat Genet 41: 199-204
42. Nair RP, Stuart P, Henseler T et al. (2000) Localization of psoriasis-susceptibility locus PSORS1 to a 60-kb interval telomeric to HLA-C. Am J Hum Genet 66:1833-44
43. Nair RP, Stuart PE, Kullavanijaya P et al. (2010) Genetic evidence for involvement of the IL23 pathway in Thai psoriatics. Arch Dermatol Res 302:139-43
44. Nestle FO, Kaplan DH, Barker J (2009) Psoriasis. N Engl J Med 361:496-509
45. Nikamo P, Ståhle M (2012) Cost-effective HLA-Cw06:02 typing in a Caucasian population. Exper Dermatol 21:221-3
46. Nunez C, Dema B, Cenit MC et al. (2008) IL23R: a susceptibility locus for celiac disease and multiple sclerosis? Gene Immun 9:289-93
47. Onoufriadis A, Simpson Michael A, Pink Andrew E et al. (2011) Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet 89: 432-7
48. Popa OM, Kriegova E, Popa L et al. (2013) Association study in Romanians confirms IL23A gene haplotype block rs2066808/rs11171806 as conferring risk to psoriatic arthritis. Cytokine 63:67-73
49. Purcell S, Neale B, Todd-Brown K et al. (2007) PLINK: A tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559-75
50. Safrany E, Pazar B, Csongei V et al. (2009) Variants of the IL23R gene are associated with ankylosing spondylitis but not with Sjogren syndrome in Hungarian population samples. Scand J Immunol 70:68-74
51. Safrany E, Szabo M, Szell M et al. (2013) Difference of interleukin-23 receptor gene haplotype variants in ulcerative colitis compared to Crohn's disease and psoriasis. Inflamm Res 62:195-200
52. Safrany E, Szell M, Csongei V et al. (2011) Polymorphisms of the IL23R gene are associated with psoriasis but not with immunoglobulin A nephropathy in a Hungarian population. Inflammation 34:603-8
53. Sidák Z (1967) Rectangular confidence regions for the means of multivariate normal distributions. J Am Stat Assoc 62:626-33
54. Strange A, Capon F, Spencer CC et al. (2010) A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet 42:985-90
55. Tsoi LC, Spain SL, Knight J et al. (2012) Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nat Genet 44:1341-8
56. Wang WJ, Yin XY, Zuo XB et al. (2012) Gene-gene interactions in IL23/Th17 pathway contribute to psoriasis susceptibility in Chinese Han population. J Eur Acad Dermatol Venereol 27:1156-62 10.1111/j.1468-3083.2012.04683.x
57. Yin X, Cheng H, Zhang R et al. (2014) Combined effect of five single nucleotide polymorphisms related to IL23/Th17 pathway in the risk of psoriasis. Immunogenetics 66:215-8
58. Zheng H-F, Zhang C, Sun L-D et al. (2010) A single nucleotide polymorphism of MHC region is associated with subphenotypes of Psoriasis in Chinese population. J Dermatol Sci 59:50-2